Moreno, C., Aiello, A., Di Virgilio, R., Mazzotta, V. and Antinori, A. (2025) “Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19”, Global and Regional Health Technology Assessment, 11(1), pp. 168–176. doi: 10.33393/grhta.2024.3403.